Latest Breaking News On - Kevin haigis - Page 3 : vimarsana.com

This 30-year collaboration is unique in its longevity and open scientific exchange. Aiming to accelerate the translation of scientific discoveries into improved cancer therapies, Dana-Farber Cancer Institute and Novartis have renewed a longstanding research collaboration and – for the first time – are inviting grant applications from a broad range of Boston academic medical institutions. Under this renewal, more than $11 million will be available annually for research funding through the Dana-Farber/Novartis Drug Discovery and Translational Research Program (DDTRP). The collaboration, which began in 1992, brings together scientists from Dana-Farber and Novartis to work on drug discovery and development efforts and has supported more than 700 research projects since inception.

United statesHarvard school of public healthDana farber cancer instituteWilliam hahnJay bradnerJames griffinPiotr sicinskiAnne fasslKevin haigisMichael eckBroad instituteNovartis institutes for biomedical researchTranslational research programBeth israel deaconess medical centerDrug administrationHarvard medical school